Metastatic Non-Small Cell Lung Cancer

DBCOND0043377NeoplasmsRespiratory Tract Diseases

Metastatic Non-Small Cell Lung Cancer is the indication for 38 drugs in DrugBank. It is covered by 93 curated, structured indications.

Also known as
Metastatic NSCLC · Metastatic Non-Small Cell Lung Carcinoma · Metastatic Non-small Cell Lung Cancer (NSCLC) · Metastatic Nonsmall Cell Lung Cancer · Metastatic Non-small Cell Lung Cancers
Classified under
Indicated drugs

and 13 more with a free account

Resolves to

Vocabularies
SNOMED CT457721000124104MedDRA10025055UMLSC0278987

What you can answer from here — as of October 03, 2026

38Indicated drugsWith each drug's targets and mechanism
Sign in
93Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
401Clinical trialsPhase, status and sponsor resolved per trial
Sign in
7Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Metastatic Non-Small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In